共 50 条
- [45] Re: Oncologic Outcomes and Survival in pT0 Tumors After Radical Cystectomy in Patients Without Neoadjuvant Chemotherapy: Results from a Large Multicentre Collaborative Study Editorial Comment JOURNAL OF UROLOGY, 2013, 189 (01): : 72 - 72
- [46] FINAL PATHOLOGIC STAGE AFTER NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR BLADDER CANCER: DOES PT0 PREDICT BETTER SURVIVAL THAN PTA/PTIS/PT1? JOURNAL OF UROLOGY, 2015, 193 (04): : E841 - E841
- [47] COULD ADJUVANT CHEMOTHERAPY HAVE THERAPEUTIC BENEFIT AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH EQUAL TO OR GREATER THAN PT3 MUSCLE INVASIVE BLADDER CANCER? JOURNAL OF UROLOGY, 2017, 197 (04): : E433 - E433
- [48] No Survival Benefit From Postoperative Adjuvant Chemotherapy After D2 Radical Resection for the Patients With Stage II Gastric Cancer AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (03): : 309 - 313
- [49] Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients Annals of Surgical Oncology, 2015, 22 : 642 - 648
- [50] ADJUVANT PLATINUM-BASED CHEMOTHERAPY IMPROVED THE PROGNOSIS OF PATIENTS WITH PT3N0/XM0 UPPER URINARY TRACT CARCINOMA JOURNAL OF UROLOGY, 2011, 185 (04): : E272 - E272